BOSTON— Gary Kaufman, co-founder and chief operating officer of ABI-LAB, a leading biotech incubator, will be a featured speaker at the Boston Life Sciences, Biotech, Pharma, and Medical Facilities Conference on April 17, 2025, at the Burlington Marriott Hotel in Burlington, MA.
Hosted by the Boston Real Estate Times and supported by Life Sciences Times, the conference will run from 7:00 AM to 10:00 AM, bringing together industry leaders to explore emerging trends, opportunities, and challenges in life sciences, biotech, and healthcare facilities.
As COO of ABI-LAB, Kaufman has played a pivotal role in fostering biotech innovation. An active angel investor, he is currently developing an investment vehicle to support two to four new biotech companies annually. His entrepreneurial background spans over 30 years, with expertise in consumer-focused businesses, real estate development, and startup ecosystems. He is also the president of Shelby Enterprises Inc., a commercial and residential real estate firm, and co-founder and vice chairman of the Metrowest Life Sciences Network, which promotes professional networking and industry growth in the Metrowest region.
Kaufman holds a BS in Management Science from Bridgewater State College and has pursued advanced studies at Tel Aviv University and Harvard University.
ABI-LAB, headquartered in Natick, MA, provides state-of-the-art lab spaces designed to accelerate the growth of early-stage and expanding life sciences companies by removing operational and financial barriers. The company recently opened its third facility, bringing its total footprint to 112,000 square feet. Its innovation labs feature advanced instrumentation, deionized water, CO₂, gas, backup generators, and HVAC systems for BL1 and BL2 applications.
Key Takeaways from the Conference:
- Market Overview: An in-depth analysis of the current health of the Life Sciences, biotech, and healthcare facilities market, addressing emerging challenges and areas of weakness.
- Impact of AI and Policy Changes: Examine how Artificial Intelligence (AI) and emerging technologies are influencing the industry and explore the potential consequences of shifting policies, particularly those introduced under the Trump administration, as federal research funding faces potential reductions.
- Recovery Timeline: Gain insights into the anticipated timeline for the full recovery of the Life Sciences sector and what will be required to stabilize the market.
- Vacancy and Rent Trends: With a 26.9% vacancy rate in Life Sciences facilities, discussions will center on the future of rents and how landlords and developers are adapting to new market conditions.
- Available Space: Explore strategies for utilizing over 15 million square feet of available Life Sciences space in the Greater Boston area, and the implications this surplus will have on the sector’s future.
- Investor Sentiment: Get a comprehensive look into both the short-term and long-term outlooks for venture capital funding in Life Sciences and biotech, alongside strategies for attracting investment.
The conference promises to be an invaluable gathering for thought leaders, industry professionals, investors, and developers eager to engage in meaningful discussions on navigating the current challenges while seizing opportunities in this rapidly evolving sector.
Registration & Sponsorship
To register for the conference, please click here (early bird rates available until March 20, 2025).
For more information on sponsorship opportunities or to inquire about speaking engagements, please contact us at: events@MishraGroup.com.
Don’t miss this chance to connect with the leading voices shaping the future of Life Sciences, Biotech, Pharma, and Healthcare in the Greater Boston area.
